New York

121,203
Registered Patient Population

0.62%
of Total Population Represented by Patients

38
Total Medical Retail Locations Currently in Operation

3,190 : 1
Patients : Retail

Medical cannabis is legal in New York, however home cultivation is not. Patients and caregivers may purchase a 30 day supply from dispensaries but the smoking of cannabis is prohibited. Patients may use liquid, pill or vaporized delivery methods. New York does not recognize out of state medical cannabis cards. Patients report that few dispensaries and high prices present barriers to access.

2021 Update: As of March 31, 2021, New Yorkers 21+ are authorized to possess and use cannabis, however adult use sales will not begin until the summer of 2022.

Patient Rights and Civil Protection

72/100

Access to Medicine

60/100

Functionality

75/100

Consumer Safety and Provider Requirements

74.67/100

Dispensing	20.67/25
Staff Training	3/5
Standard Operating Procedures	5/5
– Facility Sanitary Conditions	1.25/1.25
– Storage Protocols	1.25/1.25
– Reasonable Security Protocols	1.25/1.25
– Inventory Control	1.25/1.25
Recall Protocol and Adverse Event Reporting	5/5
Product Labeling	2.67/5
– Product Contents, Including Source Material Identification	1.67/1.67
– Allergens	0/1.67
– Potency/Compound Identification	1/1.67
Required Testing	5/5
– Active Compound Identification	1.67/1.67
– Contaminants	1.67/1.67
– Potency	1.67/1.67
Grow/Cultivation	21/25
Staff Training	3/5
Standard Operating Procedures	5/5
– Facility and Equipment Sanitary Conditions	0.71/0.71
– Workforce Safety Protocols	0.71/0.71
– Storage Protocols (Short-Term and Long-Term Storage)	0.71/0.71
– Reasonable Security Protocols	0.71/0.71
– Batch and Lot Tracking	0.71/0.71
– Disposal/Waste	0.71/0.71
– Water Management	0.71/0.71
Pesticide Guidance	3/5
– Pesticide Guidance	2/2.5
– Pesticide Labeling	1/2.5
Required Testing	5/5
– Active Ingredient Identification	1.25/1.25
– Contaminants	1.25/1.25
– Potency	1.25/1.25
– Sample Retention	1.25/1.25
Recall Protocol and Adverse Event Reporting	5/5
Manufacturing	23/25
Staff Training	3/5
Standard Operating Procedures	5/5
– Facility and Equipment Sanitary Conditions	1/1
– Workforce Safety Protocols	1/1
– Storage Protocols	1/1
– Reasonable Security Protocols	1/1
– Batch and Lot Tracking	1/1
Product Labeling	5/5
– Product Contents, Including Source Material Identification	1.67/1.67
– Allergens	1.67/1.67
– Potency and Compound Information	1.67/1.67
Required Testing	5/5
– Active Ingredient Identification	1/1
– Contaminants	1/1
– Potency	1/1
– Shelf Life Testing	1/1
– Sample Retention	1/1
Recall Protocol and Adverse Event Reporting	5/5
Laboratory Operations	10/25
Staff Training	5/5
Method Validation in Accordance with AHP Guidelines	0/5
Result Reporting	0/5
Independent or Third Party	0/5
Standard Operating Procedures and Protocols	5/5
– Equipment and Instrument Calibration	0.83/0.83
– Sample Tracking	0.83/0.83
– Facility and Equipment Sanitary Conditions	0.83/0.83
– Disposal/Waste	0.83/0.83
– Storage Protocols	0.83/0.83
– Workforce Safety Protocols	0.83/0.83